Scarica l'app Stockscreener
30.88
2.46%
0.74
Precedente Chiudi:
$30.14
Aprire:
$30.14
Volume 24 ore:
1.08M
Relative Volume:
1.00
Capitalizzazione di mercato:
$3.24B
Reddito:
-
Utile/perdita netta:
-
Rapporto P/E:
-
EPS:
-
Flusso di cassa netto:
-
1 W Prestazione:
-7.41%
1M Prestazione:
-21.38%
6M Prestazione:
-2.43%
1 anno Prestazione:
+0.00%
Intervallo 1D:
$29.48
$31.37
Intervallo di 1 settimana:
$28.91
$35.64
Portata 52W:
$12.30
$47.40
Metsera Inc Stock (MTSR) Company Profile
Nome
Metsera Inc
Settore
Industria
Telefono
(212) 784-6595
Indirizzo
3 WORLD TRADE CENTER, NEW YORK
Confronta MTSR con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
MTSR
Metsera Inc
|
30.88 | 3.17B | 0 | 0 | 0 | 0.00 |
|
VRTX
Vertex Pharmaceuticals Inc
|
387.77 | 96.01B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
556.55 | 57.86B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
429.93 | 57.02B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
637.56 | 39.10B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.10 | 34.45B | 3.81B | -644.79M | -669.77M | -6.24 |
Metsera Inc Stock (MTSR) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-06-20 | Iniziato | Wells Fargo | Overweight |
| 2025-02-25 | Iniziato | BofA Securities | Buy |
| 2025-02-25 | Iniziato | Evercore ISI | Outperform |
| 2025-02-25 | Iniziato | Guggenheim | Buy |
Metsera Inc Borsa (MTSR) Ultime notizie
Sector ETF Data Correlates with Strength in Metsera Inc.Secure Return Focused Investment Plan Released - beatles.ru
Metsera Inc (MTSR) Six Month Summary: The Bright Spot in a Quiet Biotech Year - Smartkarma
Metsera, Inc. Reports Q2 2025 Financial Progress - The Globe and Mail
Watch for Bullish Crossover in Metsera Inc.Quick Gain Stock Watch With Indicators Reviewed - metal.it
What is Metsera Inc. company’s growth strategyPhenomenal trading returns - Jammu Links News
What are the latest earnings results for Metsera Inc.Unlock your portfolio’s hidden potential - Jammu Links News
Why is Metsera Inc. stock attracting strong analyst attentionUnlock expert insights for smarter investing - Jammu Links News
How volatile is Metsera Inc. stock compared to the marketBuild a diversified portfolio for risk mitigation - Jammu Links News
Is it the right time to buy Metsera Inc. stockFree Stock Market Beginners Guide - Jammu Links News
What are Metsera Inc. company’s key revenue driversUnlock powerful trading techniques - Jammu Links News
What are analysts’ price targets for Metsera Inc. in the next 12 monthsBreakthrough financial growth - Jammu Links News
What catalysts could drive Metsera Inc. stock higher in 2025Get timely alerts on market opportunities - Jammu Links News
Is Metsera Inc. a growth stock or a value stockGet exclusive market analysis for investors - Jammu Links News
How strong is Metsera Inc. company’s balance sheetBuild wealth with high-performing stocks - Jammu Links News
We're Hopeful That Metsera (NASDAQ:MTSR) Will Use Its Cash Wisely - 富途牛牛
Metsera Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingDay Trading Signals With High Precision Reviewed - metal.it
Metsera, Inc. Lock-Up Agreement Expiration: 30-JUL-2025 - AInvest
Metsera stock rating reiterated by Cantor Fitzgerald ahead of key updates - Investing.com Nigeria
Guggenheim Maintains Metsera(MTSR.US) With Buy Rating, Maintains Target Price $62 - 富途牛牛
Metsera, Inc. Poised for Growth: Anticipated Catalysts and Clinical Trial Success Drive Buy Rating - TipRanks
What makes Metsera Inc. stock price move sharplyBuy Low Sell High Stock Watch Strategy in Focus - metal.it
Metsera reports Q2 EPS (66c), consensus (68c) - TipRanks
Metsera, Inc.: Why Shares Are on the Rise - TipRanks
Metsera Posts Narrower Q2 Loss - MarketScreener
Metsera shares tumble as quarterly loss worse than expected By Investing.com - Investing.com Canada
Metsera shares tumble as quarterly loss worse than expected - Investing.com
Metsera Reports Second Quarter 2025 Financial Results and Continued Portfolio Progress - GlobeNewswire
Metsera Obesity Drug Achieves 8.4% Weight Loss in 5 Weeks; Multiple Trial Results Coming in 2025 - Stock Titan
Recent Price Trend in Metsera Inc. (MTSR) is Your Friend, Here's Why - Yahoo Finance
Chartists Watching For Breakout in Metsera Inc.Real Time Alerts Based on AI Prediction Triggered - metal.it
Should I hold or sell Metsera Inc. stock in 2025Stock Market Review That Work - jammulinksnews.com
What is the dividend policy of Metsera Inc. stockExpert guidance for superior capital growth - Jammu Links News
Does Metsera Inc. stock perform well during market downturnsUnmatched market performance - jammulinksnews.com
Metsera Inc Azioni (MTSR) Dati Finanziari
Non sono disponibili dati finanziari per Metsera Inc (MTSR). Controlla altri titoli per ulteriori informazioni.
Reddito
Reddito netto
Flusso di cassa
EPS
0.91%
3.06%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):